| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.63B | +11.1% |
| Gross profit | ¥0.17B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | +200.9% |
| Gross margin | 26.5% | Net margin 1.3% |
| Revenue Q/Q | +9.7% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.46B | 73.5% |
| R&D | ¥0.03B | 5.3% |
| SG&A | ¥0.11B | 17.4% |
| Tax & other | ¥0.00B | 0.5% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
赛托生物 ・ 海辰药业 ・ 奥联电子 ・ 美联新材 ・ 天铁科技 ・ 熙菱信息 ・ 江龙船艇 ・ 移为通信 ・ 万里马 ・ 华凯易佰 ・ 新雷能 ・ ST朗进
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies